1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Oral Contrast Agent Revenue
1.4 Market Analysis by Type
1.4.1 Global Oral Contrast Agent Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Barium-based Contrast Media
1.4.3 Iodinated Contrast Media
1.4.4 Gadolinium-based Contrast Media
1.4.5 Microbubble Contrast Media
1.5 Market by Application
1.5.1 Global Oral Contrast Agent Market Share by Application: 2021-2026
1.5.2 Cardiovascular Disorders
1.5.3 Cancer
1.5.4 Gastrointestinal Disorders
1.5.5 Musculoskeletal Disorders
1.5.6 Neurological Disorders
1.5.7 Nephrological Disorders
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Oral Contrast Agent Market
1.8.1 Global Oral Contrast Agent Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Oral Contrast Agent Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Oral Contrast Agent Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Oral Contrast Agent Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Oral Contrast Agent Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Oral Contrast Agent Sales Volume Market Share by Region (2015-2020)
3.2 Global Oral Contrast Agent Sales Revenue Market Share by Region (2015-2020)
3.3 North America Oral Contrast Agent Sales Volume
3.3.1 North America Oral Contrast Agent Sales Volume Growth Rate (2015-2020)
3.3.2 North America Oral Contrast Agent Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Oral Contrast Agent Sales Volume
3.4.1 East Asia Oral Contrast Agent Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Oral Contrast Agent Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Oral Contrast Agent Sales Volume (2015-2020)
3.5.1 Europe Oral Contrast Agent Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Oral Contrast Agent Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Oral Contrast Agent Sales Volume (2015-2020)
3.6.1 South Asia Oral Contrast Agent Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Oral Contrast Agent Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Oral Contrast Agent Sales Volume (2015-2020)
3.7.1 Southeast Asia Oral Contrast Agent Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Oral Contrast Agent Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Oral Contrast Agent Sales Volume (2015-2020)
3.8.1 Middle East Oral Contrast Agent Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Oral Contrast Agent Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Oral Contrast Agent Sales Volume (2015-2020)
3.9.1 Africa Oral Contrast Agent Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Oral Contrast Agent Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Oral Contrast Agent Sales Volume (2015-2020)
3.10.1 Oceania Oral Contrast Agent Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Oral Contrast Agent Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Oral Contrast Agent Sales Volume (2015-2020)
3.11.1 South America Oral Contrast Agent Sales Volume Growth Rate (2015-2020)
3.11.2 South America Oral Contrast Agent Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Oral Contrast Agent Sales Volume (2015-2020)
3.12.1 Rest of the World Oral Contrast Agent Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Oral Contrast Agent Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Oral Contrast Agent Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Oral Contrast Agent Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Oral Contrast Agent Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Oral Contrast Agent Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Oral Contrast Agent Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Oral Contrast Agent Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Oral Contrast Agent Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Oral Contrast Agent Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Oral Contrast Agent Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Oral Contrast Agent Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Oral Contrast Agent Sales Volume Market Share by Type (2015-2020)
14.2 Global Oral Contrast Agent Sales Revenue Market Share by Type (2015-2020)
14.3 Global Oral Contrast Agent Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Oral Contrast Agent Consumption Volume by Application (2015-2020)
15.2 Global Oral Contrast Agent Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Oral Contrast Agent Business
16.1 GE Healthcare (US)
16.1.1 GE Healthcare (US) Company Profile
16.1.2 GE Healthcare (US) Oral Contrast Agent Product Specification
16.1.3 GE Healthcare (US) Oral Contrast Agent Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 J.B. Chemicals and Pharmaceuticals (India)
16.2.1 J.B. Chemicals and Pharmaceuticals (India) Company Profile
16.2.2 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Product Specification
16.2.3 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Guerbet (France)
16.3.1 Guerbet (France) Company Profile
16.3.2 Guerbet (France) Oral Contrast Agent Product Specification
16.3.3 Guerbet (France) Oral Contrast Agent Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Bracco Imaging (Italy)
16.4.1 Bracco Imaging (Italy) Company Profile
16.4.2 Bracco Imaging (Italy) Oral Contrast Agent Product Specification
16.4.3 Bracco Imaging (Italy) Oral Contrast Agent Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Unijules Life Sciences (India)
16.5.1 Unijules Life Sciences (India) Company Profile
16.5.2 Unijules Life Sciences (India) Oral Contrast Agent Product Specification
16.5.3 Unijules Life Sciences (India) Oral Contrast Agent Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Bayer HealthCare (Germany)
16.6.1 Bayer HealthCare (Germany) Company Profile
16.6.2 Bayer HealthCare (Germany) Oral Contrast Agent Product Specification
16.6.3 Bayer HealthCare (Germany) Oral Contrast Agent Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Taejoon Pharm (South Korea)
16.7.1 Taejoon Pharm (South Korea) Company Profile
16.7.2 Taejoon Pharm (South Korea) Oral Contrast Agent Product Specification
16.7.3 Taejoon Pharm (South Korea) Oral Contrast Agent Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Daiichi Sankyo (Japan)
16.8.1 Daiichi Sankyo (Japan) Company Profile
16.8.2 Daiichi Sankyo (Japan) Oral Contrast Agent Product Specification
16.8.3 Daiichi Sankyo (Japan) Oral Contrast Agent Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Lantheus (US)
16.9.1 Lantheus (US) Company Profile
16.9.2 Lantheus (US) Oral Contrast Agent Product Specification
16.9.3 Lantheus (US) Oral Contrast Agent Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 Spago Nanomedicine (Sweden)
16.10.1 Spago Nanomedicine (Sweden) Company Profile
16.10.2 Spago Nanomedicine (Sweden) Oral Contrast Agent Product Specification
16.10.3 Spago Nanomedicine (Sweden) Oral Contrast Agent Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 Jodas (India)
16.11.1 Jodas (India) Company Profile
16.11.2 Jodas (India) Oral Contrast Agent Product Specification
16.11.3 Jodas (India) Oral Contrast Agent Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 Magnus Health (India)
16.12.1 Magnus Health (India) Company Profile
16.12.2 Magnus Health (India) Oral Contrast Agent Product Specification
16.12.3 Magnus Health (India) Oral Contrast Agent Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Oral Contrast Agent Manufacturing Cost Analysis
17.1 Oral Contrast Agent Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Oral Contrast Agent
17.4 Oral Contrast Agent Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Oral Contrast Agent Distributors List
18.3 Oral Contrast Agent Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Oral Contrast Agent (2021-2026)
20.2 Global Forecasted Revenue of Oral Contrast Agent (2021-2026)
20.3 Global Forecasted Price of Oral Contrast Agent (2015-2026)
20.4 Global Forecasted Production of Oral Contrast Agent by Region (2021-2026)
20.4.1 North America Oral Contrast Agent Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Oral Contrast Agent Production, Revenue Forecast (2021-2026)
20.4.3 Europe Oral Contrast Agent Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Oral Contrast Agent Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Oral Contrast Agent Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Oral Contrast Agent Production, Revenue Forecast (2021-2026)
20.4.7 Africa Oral Contrast Agent Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Oral Contrast Agent Production, Revenue Forecast (2021-2026)
20.4.9 South America Oral Contrast Agent Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Oral Contrast Agent Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Oral Contrast Agent by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Oral Contrast Agent by Country
21.2 East Asia Market Forecasted Consumption of Oral Contrast Agent by Country
21.3 Europe Market Forecasted Consumption of Oral Contrast Agent by Countriy
21.4 South Asia Forecasted Consumption of Oral Contrast Agent by Country
21.5 Southeast Asia Forecasted Consumption of Oral Contrast Agent by Country
21.6 Middle East Forecasted Consumption of Oral Contrast Agent by Country
21.7 Africa Forecasted Consumption of Oral Contrast Agent by Country
21.8 Oceania Forecasted Consumption of Oral Contrast Agent by Country
21.9 South America Forecasted Consumption of Oral Contrast Agent by Country
21.10 Rest of the world Forecasted Consumption of Oral Contrast Agent by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer